About
Technology
Issues
FAQ
Links
Official Page
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.